Archives - Wednesday 16 July 2008
Allied Minds Backs Precision Biopsy
Published on Wednesday 16 July 2008 - 22:39 - http://www.xconomy.com/Boston-based investment firm Allied Minds has founded a new medical device company, Precision Biopsy, in cooperation with the University of Colorado. The new firm is developing an optical biopsy...
Possible Case: Diagnostic Radiation Procedures
Published on Wednesday 16 July 2008 - 20:02 - http://www.lawyersandsettlements.com/Link to Young-Onset Prostate Cancer Found
Dendreon Initiates Phase II Trial of Provenge
Published on Wednesday 16 July 2008 - 19:34 - http://www.fdanews.com/Dendreon Corporation announced that the Company has initiated a Phase 2 trial of Provenge (sipuleucel-T), Dendreon’s investigational active cellular immunotherapy for the treatment of prostate...
Imaging Advance Tracks Prostate Cancer in Lymph Nodes
Published on Wednesday 16 July 2008 - 19:19 - http://www.fdanews.com/A new imaging technique, based on an engineered version of the common cold virus, may help doctors detect the spread of prostate cancer to the lymph nodes earlier.
Safe Human enhancement of strength, speed, endurance, cognition and reducing aging effects and reducing obesity
Published on Wednesday 16 July 2008 - 19:17 - http://nextbigfuture.com/Selective androgen receptor modulators (SARM) increase the effect of steroids on muscle and decrease effects where they could cause harm such as in the prostate.Body building sites have extensive...
Company Claims Benefit for Drug Aimed at Preventing Bone Loss in Prostate Cancer
Published on Wednesday 16 July 2008 - 18:49 - http://www.medpagetoday.com/THOUSAND OAKS, Calif. -- Denosumab, an investigational fully human monoclonal antibody, reduced bone loss from androgen deprivation therapy for non-metastatic prostate cancer, according to an Amgen...
West MixJect System Selected By Watson For Use In Treatment Of Prostate Cancer
Published on Wednesday 16 July 2008 - 16:16 - http://www.pharmaceuticalonline.com/West, the world's premier manufacturer of components and systems for injectable drug delivery, announced that Watson Pharma, Inc., a subsidiary of Watson Pharmaceuticals, Inc., has selected MixJect...
Dendreon Starts Trial of Patients With Localized Prostate Cancer
Published on Wednesday 16 July 2008 - 16:13 - http://www.xconomy.com/Dendreon, the Seattle-based maker of immune-boosting therapies for cancer, said today it has started a mid-stage clinical trial of Provenge for patients with localized prostate cancer who are about...
Exposure to X-rays may Boost Prostate Cancer Risk
Published on Wednesday 16 July 2008 - 14:29 - http://www.medindia.com/A new study conducted by experts at The University of Nottingham has cast light on a possible link between x-rays and pr
Infinity, AZ halt prostate cancer trial
Published on Wednesday 16 July 2008 - 14:26 - http://www.fiercebiotech.com/Infinity Pharmaceuticals' shares fell on the news that it has halted a Phase II trial of IPI-504 for prostate cancer. The company, which partnered with MedImmune/AstraZeneca on the drug, said it...
